(Q68424229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

title

Phenotypic analyses of lymphokine-activated killer cells that release interferon gamma and tumor necrosis factor alpha (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

author name string

A S Chong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

B Ybarrondo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

W J Grimes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

E M Hersh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

P Scuderi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

24 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

255-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01789178

24 September 2019

exact match

0 references

cites work

Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes

1 reference

12 December 2020

Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor

1 reference

12 December 2020

Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes

1 reference

12 December 2020

Human T cells from autoimmune and normal individuals can produce tumor necrosis factor

1 reference

12 December 2020

Raised serum levels of tumour necrosis factor in parasitic infections

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

12 December 2020

Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody

1 reference

12 December 2020

Tumor necrosis factor (TNF).

1 reference

12 December 2020

Cytolytic and biochemical properties of cytoplasmic granules of murine lymphokine-activated killer cells

1 reference

12 December 2020

Immune interferon: a pleiotropic lymphokine with multiple effects

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon

1 reference

12 December 2020

Lack of correlation between peripheral blood lymphokine-activated killer (LAK) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2.

1 reference

12 December 2020

Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets

1 reference

12 December 2020

Cytotoxins (tumour necrosis factor, lymphotoxin and others): molecular and functional characteristics and interactions with interferons

1 reference

12 December 2020

Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis

1 reference

12 December 2020

Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01789178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2143102%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference